Atlas Trials

Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma

Clinical trial NCT02863055 · TERMINATED

Trial details

NCT number
NCT02863055
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Pleural Mesothelioma
Start date
2018-02-04
Primary completion
2023-10-12
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.